China Pharma Holding (STU:XQJ0) Total Liabilities : €7.27 Mil (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is China Pharma Holding Total Liabilities?

China Pharma Holding's Total Liabilities for the quarter that ended in Mar. 2024 was €7.27 Mil.

China Pharma Holding's quarterly Total Liabilities declined from Sep. 2023 (€8.66 Mil) to Dec. 2023 (€8.27 Mil) and declined from Dec. 2023 (€8.27 Mil) to Mar. 2024 (€7.27 Mil).

China Pharma Holding's annual Total Liabilities declined from Dec. 2021 (€14.72 Mil) to Dec. 2022 (€12.74 Mil) and declined from Dec. 2022 (€12.74 Mil) to Dec. 2023 (€8.27 Mil).

China Pharma Holding Total Liabilities Historical Data

The historical data trend for China Pharma Holding's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Pharma Holding Total Liabilities Chart

China Pharma Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

11.70

10.78

14.72

12.74

8.27

China Pharma Holding Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															11.85	10.48	8.66	8.27	7.27

China Pharma Holding Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

China Pharma Holding's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	6.255	+	(1.331	+	0.00099999999999956
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0.68	+	0)
	=	8.27

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	15.102	-	6.836
	=	8.27

China Pharma Holding's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	5.27	+	(1.315	+	-0.00099999999999956
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0.682	+	0)
	=	7.27

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	14.895	-	7.629
	=	7.27

China Pharma Holding Total Liabilities Related Terms

Thank you for viewing the detailed overview of China Pharma Holding's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

China Pharma Holding (STU:XQJ0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Pharma Holding Inc (STU:XQJ0) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

CPHI:USA

Address

Second Floor, No. 17, Jinpan Road, Hainan Province, Haikou, CHN, 570216

Website

https://www.chinapharmaholdings.com

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

China Pharma Holding (STU:XQJ0) Headlines

No Headlines